DCAT Value Chain Insights Production to Prescription

Author: DCAT

DCAT Value Chain Insights' Production to Prescription podcast, presented by the Drug, Chemical & Associated Technologies Association (DCAT), features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.
Be a guest on this podcast

Language: en-us

Genres: Business, Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?
Thursday, 5 June, 2025

Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, an important barometer of the financial health of the sectors, has been under pressure with macro factors in the US on tariffs, tax & monetary policy, and drug pricing reforms contributing to uncertainty. But will the tide turn?Featuring Arda Ural, EY America Life Sciences Leader, Ernst & Young (EY)Support the show